Skip to main content
Optimi Health Corp. logo

Optimi Health Corp. — Investor Relations & Filings

Ticker · OPTI ISIN · CA68405H1001 LEI · 98450063FDFF8UD3Q652 CSE Manufacturing
Open in API
Filings indexed 276 across all filing types
Latest filing 2025-08-19 Regulatory Filings
Country CA Canada
Listing CSE OPTI

About Optimi Health Corp.

https://www.optimihealth.ca/

Optimi Health Corp. is a GMP-certified pharmaceutical drug manufacturer and end-to-end drug researcher licensed to produce and supply controlled psychedelic substances. The company specializes in the production of MDMA and psilocybin, primarily supporting psychedelic-based mental health treatments. Additionally, Optimi operates a vertically integrated functional mushroom brand, developing scalable, natural mushroom formulations aimed at the health and wellness sector. This structure allows the company to serve both regulated pharmaceutical supply chains and consumer wellness markets.

Recent filings

Filing Released Lang Actions
Other.pdf
Regulatory Filings
2025-08-19 English
Management information circular - English.pdf
Proxy Solicitation & Information Statement Classification · 93% confidence The document is a Notice of Annual General and Special Meeting and the accompanying Management Information Circular, which are proxy materials sent to shareholders to solicit votes and provide information ahead of the meeting. This aligns precisely with the “Proxy Solicitation & Information Statement” category rather than an AGM presentation or the actual annual report.
2025-08-19 English
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a Form of Proxy soliciting votes for the Annual General & Special Meeting of Optimi Health Corp., including instructions on appointing a proxyholder and management’s voting recommendations for resolutions. This clearly falls under materials provided to shareholders to request votes for a meeting, matching the definition of Proxy Solicitation & Information Statement.
2025-08-19 English
Notice of meeting - English.pdf
Proxy Solicitation & Information Statement Classification · 71% confidence The document is the official Notice of the Annual General and Special Meeting of shareholders, detailing the date/time/location, meeting agenda (e.g., election of directors, appointment of auditors, equity plan approval, share consolidation), and instructions for proxy voting. It is part of the proxy materials sent to shareholders to solicit their votes and provide meeting information. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2025-08-19 English
Other.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Voting Instruction Form (VIF) soliciting proxies and vote instructions for Optimi Health Corp.’s Annual General & Special Meeting, detailing how shareholders can appoint management nominees or others to vote, listing resolutions and voting methods. This corresponds to proxy solicitation materials provided to shareholders ahead of a meeting. Therefore, it is a Proxy Solicitation & Information Statement.
2025-08-19 English
Other.pdf
Regulatory Filings Classification · 85% confidence The document is a shareholder mail‐out form allowing recipients to request interim or annual financial statements and MD&A by mail or email. It is not the financial statements themselves (so not an Interim/Quarterly Report or Annual Report), nor is it an earnings release or proxy solicitation. It is a regulatory‐required mailing form with no other specific category, so it falls into the fallback “Regulatory Filings” (RNS) classification.
2025-08-19 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.